{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:13:15Z","timestamp":1783437195224,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112557","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T08:54:28Z","timestamp":1719392068000},"page":"112557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation"],"prefix":"10.1016","volume":"138","author":[{"given":"Dafei","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangxue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-6350","authenticated-orcid":false,"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112557_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102861","article-title":"Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target","volume":"132","author":"Lou","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112557_b0010","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fimmu.2019.01684","article-title":"Could GILZ Be the answer to glucocorticoid toxicity in lupus?","volume":"10","author":"Flynn","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102873","article-title":"B cell-targeted therapies in systemic lupus erythematosus","volume":"132","author":"Arbitman","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112557_b0020","article-title":"New biologics and targeted therapies in systemic lupus: from new molecular targets to new indications","volume":"90","author":"Felten","year":"2023","journal-title":"A Systematic Review. Joint Bone Spine."},{"key":"10.1016\/j.intimp.2024.112557_b0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2016.158","article-title":"Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE","volume":"12","author":"Dorner","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112557_b0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cmi.2017.133","article-title":"Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity","volume":"15","author":"Wu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-021-00725-x","article-title":"AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.112557_b0040","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112557_b0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/imr.12374","article-title":"Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases","volume":"269","author":"Lino","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112557_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109778","article-title":"The role of B-cell ferroptosis in the pathogenesis of systemic lupus erythematosus","volume":"256","author":"Chen","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0055","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1038\/cddis.2014.375","article-title":"Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus","volume":"5","author":"Fan","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112557_b0060","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.167.4.2361","article-title":"Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus","volume":"167","author":"Arce","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clim.2007.10.004","article-title":"A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE","volume":"126","author":"Nicholas","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0070","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41590-019-0419-9","article-title":"Epigenetic programming underpins B cell dysfunction in human SLE","volume":"20","author":"Scharer","year":"2019","journal-title":"Nat. Immunol."},{"issue":"725\u201339","key":"10.1016\/j.intimp.2024.112557_b0075","first-page":"e6","article-title":"Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112557_b0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/ard-2023-224453","article-title":"Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus","volume":"82","author":"Liu","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112557_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/imr.12988","article-title":"The gene regulatory network controlling plasma cell function","volume":"303","author":"Trezise","year":"2021","journal-title":"Immunol. Rev."},{"issue":"702\u201315","key":"10.1016\/j.intimp.2024.112557_b0090","first-page":"e4","article-title":"T follicular helper cell-germinal center b cell interaction strength regulates entry into plasma cell or recycling germinal center cell fate","volume":"48","author":"Ise","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112557_b0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.molimm.2013.05.241","article-title":"Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus","volume":"56","author":"Luo","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.20111195","article-title":"Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity","volume":"209","author":"Biswas","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112557_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107452","article-title":"Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony","volume":"207","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2024.112557_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2019.00057","article-title":"The regulatory effects of paeoniflorin and its derivative paeoniflorin-6'-O-benzene sulfonate CP-25 on inflammation and immune diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0115","doi-asserted-by":"crossref","first-page":"5161890","DOI":"10.1155\/2022\/5161890","article-title":"Paeoniflorin inhibits LPS-induced activation of splenic CD4(+) T lymphocytes and relieves pathological symptoms in MRL\/lpr mice by suppressing IRAK1 signaling","volume":"2022","author":"Ji","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2024.112557_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114434","article-title":"Paeoniflorin ameliorates murine lupus nephritis by increasing CD4(+)Foxp3(+) Treg cells via enhancing mTNFalpha-TNFR2 pathway","volume":"185","author":"Liang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41401-020-00510-6","article-title":"CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases","volume":"41","author":"Yang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2024.112557_b0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ptr.7657","article-title":"Paeoniflorin-6'-O-benzene sulfonate protected the intestinal epithelial barrier by restoring the inhibitory effect of GRK2 and beta-arrestin 2 on ERK1\/2-NF-kappaB","volume":"37","author":"Jiang","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.112557_b0135","doi-asserted-by":"crossref","first-page":"1041671","DOI":"10.3389\/fphar.2022.1041671","article-title":"CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0140","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.apsb.2021.01.015","article-title":"Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2024.112557_b0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.apsb.2023.09.013","article-title":"GRK2 inhibits Flt-1(+) macrophage infiltration and its proangiogenic properties in rheumatoid arthritis","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2024.112557_b0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41374-020-0453-0","article-title":"CP-25 alleviates antigen-induced experimental Sjogren's syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration","volume":"101","author":"Wu","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2024.112557_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106199","article-title":"Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjogren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway","volume":"80","author":"Chen","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41401-018-0169-5","article-title":"Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-kappaB signaling: comparison with biological agents","volume":"40","author":"Shu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2024.112557_b0165","first-page":"965","article-title":"CP-25 inhibits Th17 cell differentiation and improves kidney injury in MRL\/lpr lupus mice","volume":"37","author":"Huang","year":"2021","journal-title":"Chin. Pharmacol. Bulletin."},{"key":"10.1016\/j.intimp.2024.112557_b0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.omtn.2021.12.022","article-title":"MicroRNA-10b promotes arthritis development by disrupting CD4(+) T cell subtypes","volume":"27","author":"Tu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.intimp.2024.112557_b0175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome","volume":"25","author":"Austin","year":"1984","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112557_b0180","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1073\/pnas.93.23.12974","article-title":"Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function","volume":"93","author":"Jaber","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112557_b0185","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s10067-019-04620-3","article-title":"Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?","volume":"38","author":"Ugolini-Lopes","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112557_b0190","doi-asserted-by":"crossref","first-page":"e000366","DOI":"10.1136\/lupus-2019-000366","article-title":"Serum uric acid is associated with damage in patients with systemic lupus erythematosus","volume":"7","author":"Elera-Fitzcarrald","year":"2020","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.intimp.2024.112557_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110353","article-title":"Chloroquine inhibits NLRP3 inflammasomes activation and alleviates renal fibrosis in mouse model of hyperuricemic nephropathy with aggravation by a high-fat-diet","volume":"120","author":"Cui","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0200","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.7150\/ijms.51117","article-title":"Elevated creatinine clearance in lupus nephritis patients with normal creatinine","volume":"18","author":"Wang","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.intimp.2024.112557_b0205","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/JIR.S339744","article-title":"An analysis of the correlation between clinical indexes and pathological classifications in 202 patients with lupus nephritis","volume":"14","author":"Pan","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.112557_b0210","doi-asserted-by":"crossref","first-page":"1171318","DOI":"10.3389\/fimmu.2023.1171318","article-title":"Ferroptosis of CD163(+) tissue-infiltrating macrophages and CD10(+) PC(+) epithelial cells in lupus nephritis","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0215","doi-asserted-by":"crossref","first-page":"1185727","DOI":"10.3389\/fimmu.2023.1185727","article-title":"Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-alpha-accelerated lupus nephritis in mice","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2024.112557_b0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ni1083","article-title":"Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone","volume":"5","author":"Cinamon","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112557_b0230","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood-2008-12-192583","article-title":"Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma","volume":"114","author":"Li","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112557_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8491","article-title":"Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis","volume":"13","author":"Carlson","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112557_b0240","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112557_b0245","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112557_b0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/art.41900","article-title":"Phase III\/IV, randomized, fifty-two-week study of the efficacy and safety of belimumab in patients of black african ancestry with systemic lupus erythematosus","volume":"74","author":"Ginzler","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2024.112557_b0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112557_b0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.apsb.2016.07.001","article-title":"Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB\/c mice","volume":"7","author":"Lin","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2024.112557_b0265","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41401-020-00582-4","article-title":"BAFF, involved in B cell activation through the NF-kappaB pathway, is related to disease activity and bone destruction in rheumatoid arthritis","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2024.112557_b0270","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fphar.2017.00933","article-title":"CP-25, a novel anti-inflammatory and immunomodulatory drug, inhibits the functions of activated human B cells through regulating BAFF and TNF-alpha signaling and comparative efficacy with biological agents","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2018.00563","article-title":"A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112557_b0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2017.06.004","article-title":"Efficacy and safety of biological DMARDs modulating B cells in primary Sjogren's syndrome: systematic review and meta-analysis","volume":"85","author":"Letaief","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2024.112557_b0285","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/ard.2008.096172","article-title":"Is the blood B-cell subset profile diagnostic for Sjogren syndrome?","volume":"68","author":"Binard","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112557_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114668","article-title":"Targeting GRK2 and GRK5 for treating chronic degenerative diseases: advances and future perspectives","volume":"243","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.112557_b0295","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41401-020-00507-1","article-title":"Deficiency of beta-arrestin2 exacerbates inflammatory arthritis by facilitating plasma cell formation","volume":"42","author":"Zhou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2024.112557_b0300","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/cb3003013","article-title":"Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility","volume":"7","author":"Thal","year":"2012","journal-title":"ACS Chem. Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924010786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T22:44:44Z","timestamp":1728168284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924010786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":60,"alternative-id":["S1567576924010786"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112557","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112557"}}